Gland Pharma fundamental analysis

GLAND

2334

3.00 (0.13%)
Last updated on 22 May, 2026 | 15:52 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Gland Pharma Fundamentals

P/E Ratio

37.49

P/B Ratio

3.72

Div. Yield

0.86

Sector P/E

71.49

Sector P/B

3.47

Sec. Div. Yield

0.55

Gland Pharma Fundamentals is currently trading with a P/E Ratio of 37.49, compared to the sector average of 71.49. Its P/B Ratio stands at 3.72, while the sector’s is 3.47. In terms of returns, the stock offers a Dividend Yield of 0.86%, which is than the sector’s 0.55%.

Gland Pharma Score Card

  • price_icon
    Price

    Attractive

  • chart_icon
    Growth

    Moderate

  • quality_check
    Quality

    Good

  • quality_check
    Management

    Good

On its scorecard, Gland Pharma reflects: Price – Attractive, Growth – Moderate, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost